Phase I study of Oral gemcitabine prodrug (LY2334737) alone and in combination with erlotinib in patients with advanced solid tumors (Q84553767)
Jump to navigation
Jump to search
scientific article published on 13 July 2011
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase I study of Oral gemcitabine prodrug (LY2334737) alone and in combination with erlotinib in patients with advanced solid tumors |
scientific article published on 13 July 2011 |
Statements
Phase I study of Oral gemcitabine prodrug (LY2334737) alone and in combination with erlotinib in patients with advanced solid tumors (English)
Jos H Beijnen
Jan H M Schellens
Stijn L W Koolen
Petronella O Witteveen
Robert S Jansen
Marlies H G Langenberg
Roelien H Kronemeijer
Annemarie Nol
Ignacio Garcia-Ribas
Sophie Callies
Karim A Benhadji
Christopher A Slapak